drugset / Trial / NCT01821677
A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the efficacy of ultra low dose danazol (Optina™) for the treatment of diabetic macular edema.
Timeline
- Start
- 2013-02-26
- Primary completion
- 2014-10-30
- Completion
- 2015-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danazol | Other / unclassified | 0.5 unknown | Oral |
| Subject | Danazol | Other / unclassified | 1 unknown | Oral |